A stable full-length infectious cDNA clone of the Oshima strain of Tick-borne encephalitis virus (Far-Eastern subtype) was developed by a long high-fidelity RT-PCR and one-step cloning procedure. The infectious clone (O-IC) had four amino acid substitutions and produced smaller plaques when compared with the parent Oshima 5-10 strain. Using site-directed mutagenesis, the substitutions were reverted to restore the parent virus sequence (O-IC-pt). Although genetically identical, parent virus Oshima 5-10 and virus recovered from O-IC-pt demonstrated some biological differences that are possibly explained by the presence of quasispecies with differing virulence characteristics within the original virus population. These observations may have implications for vaccines based on modified infectious clones. It was also demonstrated that the amino acid substitution E-S 40 RP at position 40 in the envelope (E) glycoprotein was responsible for plaque size reduction, reduced infectious virus yields in cell culture and reduced mouse neurovirulence. Additionally, two amino acid substitutions in the non-structural (NS)5 protein (virus RNA-dependent RNA polymerase) NS5-V 378 RA and NS5-R 674 RK also contributed to attenuation of virulence in mice, but did not demonstrate a noticeable biological effect in baby hamster kidney cell culture. Comparative neurovirulence tests revealed how the accumulation of individual mutations (E-S 40 RP, NS5-V 378 RA and NS5-R 674 RK) can result in the attenuation of a virus.
INTRODUCTION
Tick-borne encephalitis virus (TBEV) is a species of the mammalian tick-borne group within the genus Flavivirus, family Flaviviridae . TBEV is prevalent over a wide area of Europe and Asia (Dumpis et al., 1999; Suss, 2003) and causes a variety of clinical symptoms in humans including subclinical infections, mild or severe fevers and encephalitis with serious sequelae. The virus has a significant impact on public health in these endemic regions (Haglund & Gunther, 2003; Gritsun et al., 2003b) and has been subdivided into Far-Eastern, Siberian and European subtypes (Ecker et al., 1999; Hayasaka et al., 2001; Gritsun et al., 2003a) . The Far-Eastern subtype, previously known as Russian Spring-Summer Encephalitis (RSSE) virus, causes a severe clinical manifestation and shows a higher case fatality rate (5-20 %) than other Siberian and European strains of TBEV (Shope, 1980; Dumpis et al., 1999; Korenberg & Kovalevskii, 1999 ).
The flavivirus genome (single, positive-stranded RNA, approximately 11 kb in length) encodes three structural proteins [capsid (C) protein, precursor membrane (prM) protein, and envelope (E) protein] and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5), within a single long open reading frame (ORF). The 59 and 39 termini of the genome have predicted secondary structures (Gritsun et al., 1997; Proutski et al., 1997; Rauscher et al., 1997) and contain important elements for virus replication, translation and packaging of the genome (Chambers et al., 1990; Lindenbach & Rice, 2001) .
A number of infectious cDNA clones of flaviviruses have been produced using different strategies to study the different aspects of flavivirus pathogenesis (Rice et al., 1989; Ruggli & Rice, 1999; Sumiyoshi et al., 1992; Kapoor et al., 1995; Mandl et al., 1997; Polo et al., 1997; Gritsun & Gould, 1998; Yamshchikov et al., 2001a, b; Bredenbeek et al., 2003; Zhang et al., 2001; Yun et al., 2003; Puri et al., 2000; Kinney et al., 1997; Gualano et al., 1998; Sriburi et al., 2001; Lai et al., 1991; Khromykh & Westaway, 1994; Shi et al., 2002; Campbell & Pletnev, 2000; Pletnev, 2001; Hurrelbrink et al., 1999) . There are two reports of infectious cDNA clones for TBEV, European subtype strains Neudoerfl and Hypr and Siberian subtype strain Vasilchenko (Vs) (Gritsun & Gould, 1998) . The present study reports the construction and characterization of an infectious cDNA clone of the Far-Eastern subtype TBEV Oshima 5-10 strain, which was isolated in Japan in 1995 (Takashima et al., 1997) . Genetic and biological differences between the infectious clone and the parent Oshima 5-10 virus were revealed and the parent genotype was recreated from the infectious clone by reversion of all detected amino acid substitutions. Specific mutations within the E glycoprotein and the RNAdependent RNA-polymerase (NS5) gene were shown to be responsible for modification of plaque phenotype, virus growth in cell culture and virulence for mice.
METHODS
Cells and viruses. Baby hamster kidney (BHK) cells were grown in Eagle's Minimal Essential Medium (EMEM; Nissui Pharmaceutical Co.) supplemented with 8 % fetal calf serum (FCS). TBEV strain Oshima 5-10 isolated in Japan in 1995 was used for construction of the infectious cDNA clone (Takashima et al., 1997) . The virus was propagated in 1-day-old suckling mice and stored as a 10 % mouse brain suspension (MBS).
Reverse transcription and long-PCR. Viral RNA extraction and long high-fidelity RT-PCR were described previously . Briefly, viral RNA was extracted from 10 % MBS using Catrimox (Iowa Biotechnology Corp.). The RT reaction was carried out with Superscript II reverse transcriptase (Invitrogen) and 14-mer primer (AGCGGGTGTTTTTC). For the long PCR a mixture of thermostable Red Hot DNA polymerase (Advanced Biotechnologies) and Deep Vent DNA polymerase (NEB) was used for a hot start. The PCR programme included 30 cycles of 30 s at 94 uC and 10 min at 72 uC. Primers were designed on the basis of the nucleotide sequence of Oshima 5-10 strain (Hayasaka et al., 2001; Goto et al., 2002) . The sense primer Oshi-59-long included a NotI restriction enzyme site, SP6 promoter and 28 nucleotides of 59 untranslated region (UTR) (gtcgacGCGGCCGCatttaggtgacactatagAG-ATTTTCTTGCACGTGCATGCGTTTGC). The antisense primer Oshi-39-long has a SpeI site and 35 nucleotides of 39UTR (gcacgtACTAGT-AGCGGGTGTTTTTCCGAGTCACTCATCACCTCCTT). PCR products were purified using a QIAquick PCR Purification Kit (Qiagen).
Cloning of full-length cDNA clone of TBEV Oshima strain.
Plasmid pGGVs 209 , based on pBR322 (Gritsun & Gould, 1998) , was used for the cloning of full-length RT-PCR product amplified from Oshima 5-10 virus (Fig. 1) . Plasmid pGGVs 209 was constructed from the infectious clone for TBEV Siberian strain, Vs, and contains the first 209 nucleotides of the Vs virus genome with the restriction site SpeI at position 80 and a NotI site upstream of the SP6 promoter. Plasmid pGGVs 209 and purified long-PCR product were digested with NotI and SpeI enzymes, ligated with T4 ligase (NEB) and transformed into the low-copy Able-K strain of E. coli (Stratagene) by electroporation. Bacterial cells were incubated on TYM agar plates containing 100 mg ampicillin ml 21 at 37 uC. Small colonies were chosen and grown in liquid TYM at 28 uC overnight. Plasmid DNAs were extracted and those selected by size (about 15 kb) were verified by restriction analysis to confirm the insertion of virus cDNA.
Recovery of infectious virus. Full-length bacterial clones were linearized with SpeI and transcribed into the RNA using the SP6-transcription system as described previously or alternatively using mMESSAGE mMACHINE (Ambion). To recover virus, RNA after the SP6-transcription was injected intracerebrally into the young mice. They developed encephalitis within 5-9 days .
For electroporation, the transcription samples were treated with DNase; transcribed RNA after the precipitation with LiCl was dissolved in 10 ml of water. Trypsin-treated BHK cells were washed with cold PBS three times. About 10 mg of transcribed RNA was electroporated to 5610 6 BHK cells in 500 ml of cold PBS in 0?4 cm cuvettes using a GenePulser apparatus (Bio-Rad), 1?3 kV, 25 mF and 'V, pulsed two times. After incubation at room temperature for 10 min, cells were kept at 37 uC under 5 % CO 2 .
The identification of the virus in the mouse brain or in cell supernatant medium was carried out by indirect immunofluorescence microsopy using monoclonal antibodies to the E glycoprotein as described in . The full-length clone that produced infectious virus was nominated as O-IC (Oshima virus infectious clone). In the comparative experiments to be described below the virus stocks were derived from the supernatant medium of BHK cells.
Mutagenesis of the infectious clone. A range of intermediate plasmids based on pGEM3 and pGEMT vectors (Promega) was constructed to produce reverse-mutations in the infectious clone (pGEM3-HS1, pGEM3-HS2, pGEMT-CprME and pGEMT-NS5, Fig. 1 ). Plasmid pGEM3-HS2 was constructed to introduce wild-type substitutions (NS5-T 794 , guanine 10473 and adenine 10922 in the 39UTR) to produce a full-length plasmid and virus with genotype P 40 A 378 K 674 T 794 (Fig. 1 ).
To substitute P 40 for S 40 , the parent virus genome fraction between nucleotides 242-2295 was amplified by RT-PCR and cloned (with the introduction of two flanking SpeI restriction sites) to construct plasmid pGEMT-CprME. An AvrII restriction site (cohesive ends compatible with SpeI) was introduced into the plasmid P 40 A 378 K 674 T 794 (D. Hayasaka and others, unpublished results) . This intermediate plasmid and pGEMT-CprME were used to substitute the region 242-2295 between two sets of restriction sites corresponding to AvrII or SpeI to produce a plasmid and virus with the genotype S 40 A 378 K 674 T 794 (Fig. 1) . Plasmid pGEM-3-HS1 was constructed by subcloning the region between HindIII and SpeI (nucleotides 9197-11100) of the infectious clone O-IC. The S 40 A 378 K 674 T 794 and plasmid pGEM3-HS1 were used to construct full-length plasmid and corresponding virus with genotype S 40 A 378 K 674 A 794 .
To recreate the infectious clone O-IC-pt, so that it was genetically identical to parent virus Oshima 5-10, the nucleotides 7365-11 100 of the NS5 gene were amplified from parent Oshima 5-10 virus by RT-PCR and cloned to construct a plasmid pGEMT-NS5 that was subsequently used to substitute the region between nucleotides 7365-11100 (AatII and SpeI sites) of the plasmid S 40 A 378 K 674 T 794 . All subcloned plasmids (Fig. 2) were fully sequenced to confirm their authenticity.
Sequencing of cDNA plasmid and recovered virus. Recovered viruses were used to infect BHK cells and viral RNA was extracted with Isogen Kit (Nippon Gene). RT-PCR products were amplified using a Thermo Script RT-PCR system (Invitrogen) and sequenced with DNA Sequencing Kit (ABI PRISM) using the fluorescence autosequencer (ABI PRISM 310 Genetic Analyser). To determine the sequences of the 59-and 39-ends of the recovered virus, extracted RNAs were de-capped with tobacco acid pyrophosphatase (Wako), ligated with T4 RNA ligase (Takara) and amplified by RT-PCR. depicted as an open box with genes specified through C to NS5. Untranslated regions flanking polyprotein are specified as thick black lines. The primers for amplification of virus RNA in RT (14-mer primer) and long-PCR (Oshi59-long and Oshi39-long) are indicated as thin arrows, and the SP6 promoter as a shadowed arrow. Restriction sites NotI and SpeI were used for cloning the PCR product into the plasmid pGGVs 209 based on pBR322. The restriction sites used to construct mutant plasmids and viruses are shown above. Authentic features of pBR322 are specified as restriction sites NheI and SspI, tetracycline-and ampicillinresistant genes (Tet r and Amp r ) and origin of replication. The four amino acid substitutions in the polyprotein and two nucleotide changes in the 39UTR of the infectious clone are indicated by capital letters above the genome with nucleotide positions in numbers next to arrowheads. Subcloned plasmids containing C-prM-E, NS5 and 39UTR sequences that were amplified by RT-PCR from parent Oshima 5-10 virus RNA and used for the construction of mutants viruses and revertant infectious cDNA clone O-IC-pt. O-IC plasmid (amino acid genotype P 40 A 378 K 674 A 794 ) was digested with HindIII and SpeI (between nucleotides 9197-11100) and replaced with a corresponding fragment derived from pGEM3-HS2 to produce plasmid P 40 A 378 K 674 T 794 . The plasmid S 40 A 378 K 674 T 794 was produced from plasmid P 40 A 378 K 674 T 794 by two sequential clonings: firstly, an AvrII site (cohesive ends compatible with SpeI) was introduced into the plasmid P 40 A 378 K 674 T 794 to create an intermediate plasmid (D. Hayasaka and others, unpublished results) and the fragment between nucleotides 242-2295 was replaced with a corresponding fragment from pGEMT-CprME (digested with SpeI enzyme). The sequence between nucleotides 9197-11100 of S 40 A 378 K 674 T 794 was replaced with an equivalent fragment derived from pGEM3-HS1 to create plasmid S 40 A 378 K 674 A 794 . Plasmid S 40 A 378 K 674 T 794 was digested at AatII and SpeI sites (between nucleotides 7365-11100) and replaced with a fragment of pGEMT-NS5 digested with AatII and SpeI to produce plasmid O-IC-pt. (Takashima et al., 1997) , was used to assess virus titres. Virus was adsorbed for 90 min at 37 uC on BHK cells. The inoculum was then replaced with EMEM and 5 % carboxymethyl cellulose. After incubation for 36 or 72 h, cells were fixed with methanol and incubated at 37 uC for 1 h with an appropriately diluted ascitic fluid taken from mice hyperimmunized with a tick-borne flavivirus. Following washing with PBS, fluorescein isothiocyanate-conjugated antibody against mouse IgG was added and incubated at 37 uC for 1 h. After washing with PBS, the numbers of fluorescent foci were estimated under a UV microscope. The virus titres were calculated and expressed as focus forming units per ml (f.f.u. ml 21 ).
Growth curve in cell cultures. Subconfluent BHK cells were grown as 10 6 cells per well in 12-well plates and inoculated with each parent or engineered virus at an m.o.i of 0?01 f.f.u. Viruses were diluted with medium containing 4 % FCS. After incubation for 90 min, virus inoculum was removed and the cells were washed twice in PBS. Two ml of medium was added to each well and they were then incubated at 37 uC under 5 % CO 2 . The samples were harvested at 12, 24, 36 and 48 h post-inoculation and stored in aliquots at 280 uC prior to titration.
Virulence in mice. Viruses were inoculated into 7-week-old male BALB/c mice (SLC) with body weights of about 20 g. Eight mice in each group received 50 f.f.u. of each virus intracerebrally or 1000 f.f.u. of each virus subcutaneously. Morbidity was defined as the appearance of more than 10 % weight loss or clinical signs ruffled fur and/or hunched back. Surviving mice were monitored for 28 days post-infection to obtain survival curves and mortality rates.
RESULTS

Construction of an infectious clone of TBEV Oshima strain
An infectious clone of Oshima virus was prepared using the one-step cloning procedure (Gritsun & Gould, 1998) as described in Methods. The long high-fidelity RT-PCR product, which was approximately 11 kb, appeared as a single band in agarose gels (data not shown). The cDNA was digested with NotI and SpeI and cloned into the vector pGGVs 209 as demonstrated in Fig. 1 . Ten out of 88 colonies contained full-length viral cDNA on the basis of restriction enzyme digestion patterns (data not shown). These cDNA clones were transcribed in vitro with SP6 RNA polymerase and each of the ten derived RNA preparations was either injected intracerebrally into newborn mice or electroporated into BHK cells. Four out of ten mouse litters developed encephalitis and only one of these four clones also produced virus antigen in the BHK cells as confirmed by IFA tests using TBEV-specific antibody. This clone, designated O-IC, was used for all subsequent experimental work.
To test for stability in bacteria, O-IC plasmids were transformed into E. coli strain HB101, grown for various incubation times, (8, 12, 16, 20 and 24 h) and plated on Luria Broth agar containing 100 mg ampicillin ml
21
. The colony size on the plates was unaltered after five repeated passages and after each subculture, the infectious virus was successfully rescued (data not shown). Sequencing demonstrated that plasmid O-IC and the virus which was recovered from the infectious clone O-IC were identical.
Properties of the infectious clone
Formation of fluorescent foci. Whilst carrying out the focus forming assay, we noticed that the parent Oshima 5-10 virus produced distinct fluorescent foci at 36 h postinfection (Fig. 3) . However, O-IC produced only singly infected cells within the same time period and fluorescent foci, of the same size as those produced by the parent virus at 36 h, were visualized only after an incubation period of at least 72 h (Fig. 3) .
Sequencing analysis. The complete genome sequence of the O-IC plasmid was determined and compared with the parent virus. There were nine nucleotide sequence differences between these viruses and four of the substitutions resulted in amino acid changes (Table 1) . Comparative protein alignments between all available flavivirus sequences revealed that the infectious clone had a proline in position 40 (P 40 ) of the E protein whilst the parent virus Oshima 5-10 and approximately 80 other strains of tick-borne flavivirus, plus Yellow fever virus (a mosquitoborne virus) have serine in this position (Fig. 4) . Other mosquito-borne and non-vectored flaviviruses have a threonine in this position, and both threonine and serine form a group of polar hydroxyl-containing amino acids. The substitution of threonine or seine for proline could have biological consequences because it changes the hydrophobicity of the E protein in this region.
Three other mutations mapped in the NS5 protein, in regions conserved among tick-and mosquito-borne flaviviruses. The first two substitutions within the NS5 protein V 378 RA and R 674 RK are conserved and should not change the charge or hydrophobicity of the protein. The third substitution T 794 RA is not conserved and also mapped in a highly conserved position in other viruses within the family Flaviviridae (Fig. 4) . A single amino acid substitution within the E protein reduces the size of fluorescent foci
Following the above analysis we carried out mutagenesis on the infectious clone to restore the original sequence of the parent virus and also to identify which mutation or mutations are responsible for reduction in size of fluorescent foci induced by the infectious clone. The strategy for the construction of mutant viruses is described in Methods and is illustrated in Fig. 1 . The genotypes of recovered mutant viruses are presented in Fig. 2 
Virus growth curves in cell cultures
Several conclusions arise from the comparative growth characteristics of the mutated viruses (Fig. 5) .
Firstly, there were highly significant differences (orders of magnitude) in the yields of virus at 12 h post-infection between parent virus Oshima 5-10 and genetically identical O-IC-pt virus. This was a reproducible observation that may possibly be explained by the presence of quasi-species in the original parent virus population (see Discussion).
Secondly, although newly synthesized virions began to appear for all viruses between 12-14 h post-infection, the infectious yields at each time point remained higher for S 40 A 378 K 674 T 794 virus than for P 40 A 378 K 674 T 794 and since they differ by only one amino acid in position 40 of the E protein (E-S 40 genotype against E-P 40 respectively) these results imply that a single substitution in the E gene significantly reduces virus reproduction efficiency in cell cultures.
Thirdly, there was no significant difference in the growth curves produced by O-IC-pt (S 40 V 378 R 674 T 794 ) and S 40 A 378 K 674 T 794 , despite the fact that they differ by two amino acids (NS5-V 378 RA and NS5-R 674 RK).
Therefore these growth curve experiments demonstrate that only the mutation in the E protein exerts an effect on the phenotype of the virus in cell culture. about 25 % of mice. These experiments therefore demonstrate firstly, a biological effect of NS5-V 378 RA and NS5-R 674 RK mutations that was not detectable in cell culture, and secondly it shows the cumulative effect of E-S 40 RP, NS5-V 378 RA and NS5-R 674 RK on attenuation of the virus.
Virulence for mice
Neuroinvasiveness was also compared for the same viruses, by subcutaneous inoculation of mice with 1000 f.f.u. of each virus. The results of these experiments are presented in Table 2 . All mice inoculated with parent Oshima 5-10 virus died between 8 and 12 days post-inoculation. However, all mice inoculated with O-IC-pt virus, that is the virus with an identical genotype, were still alive at 28 days postinoculation, although seven of the eight mice showed clinical signs such as paralysis or loss of body weight (Table 2) . These results may possibly be explained by the presence of virus quasi-species with different pathogenic characteristics in the original virus population (see Discussion).
Comparison of O-IC-pt and S 40 A 378 K 674 T 794 viruses that differ by two mutations in the NS5 protein, show differences in morbidity but not mortality rate, suggesting that both NS5-V 378 RA and NS5-R 674 RK in addition to neurovirulence also affect virus neuroinvasiveness. 
DISCUSSION
This is the first report of an infectious clone of a Far-Eastern subtype of TBEV that is commonly referred to as RSSE virus because the disease caused by this virus typically occurs in the spring and summer in the forested regions of FarEastern Russia, Asia and Japan (Gritsun et al., 2003b; Ecker et al., 1999; Hayasaka et al., 2001) . Infectious clones of two other TBEV subtypes, that is Western European and Siberian, were constructed previously (Gritsun & Gould, 1998; Mandl et al., 1997) . Despite their close antigenic and genetic similarity (about 96 % for amino acid sequence), TBEV strains of different subtypes cause diseases with a variety of clinical manifestations and mortality rates. According to statistical reports, Far-Eastern TBEV causes the most severe encephalitis with a higher case fatality than the European or Siberian subtypes (Gritsun et al., 2003a, b; Shope, 1980; Dumpis et al., 1999; Korenberg & Kovalevskii, 1999 ). The construction of these different but related infectious clones of TBEV therefore provides us with important tools with which to investigate and possibly to resolve the underlying basis of TBEV pathogenicity.
To construct an infectious cDNA clone of Far-Eastern subtype TBEV, we used the Oshima 5-10 strain, which was isolated in 1995 in Japan (Takashima et al., 1997) . Although only one case of human TBE has been confirmed in Japan, it is believed that TBEV emerged within the past few centuries and was distributed to a wide area of Hokkaido, the northern island of Japan (Hayasaka et al., 1999; Takeda et al., 1999) . Oshima 5-10 virus shares more than 98 % amino acid identity with Sofjin virus, the prototype Far-Eastern TBEV (Goto et al., 2002) . In addition, Oshima 5-10 virus shows similar virulence in mice with the viruses recently isolated in Far-Eastern Russia (Chiba et al., 1999; Hayasaka et al., 1999 Hayasaka et al., , 2001 ).
In this study we constructed an infectious clone using the strategy described for the Siberian strain of TBEV, Vs, . Long high-fidelity PCR and one-step cloning procedures were employed to produce bacterial clones containing full-length molecules of TBEV. The bacterial cells were routinely propagated at 28 u C to reduce the mutation rate introduced by the bacteria. We checked 88 clones from bacterial colonies after transformation and ten contained full-length virus sequences. One clone (O-IC) that was infectious for mice and BHK cells was selected for further analysis. A separate non-infectious fulllength clone that we sequenced had 15 nucleotide differences from the parent virus and a single nucleotide deletion at position 5120 in the NS3 protein region (data not shown). A similar proportion of 1/12 between infectious and noninfectious cDNA molecules was also detected after cloning the Siberian TBEV strain (Gritsun & Gould, 1998) . The fact that bacteria select in favour of non-infectious molecules has been explained by low level expression of regions of flavivirus polyprotein with transmembrane domains that could be toxic for bacteria; therefore clones that accidentally acquired lethal mutations might have a selective advantage (Yamshchikov et al., 2001a) . Nevertheless, although only one infectious clone was obtained, and it was stable in E. coli strain Able-K and also HB101 at both 28 u C and 37 u C. and O-IC-pt) were also stable. Therefore, the infectious clone will be highly exploitable for genetic manipulations.
Four amino acid substitutions, one mapping within the E glycoprotein and the other three within the NS5 gene (RNAdependent RNA polymerase), were revealed between parent Oshima 5-10 and the original infectious clone O-IC (Table 1) . O-IC virus also differed from parent virus in the infectious focus test, producing infectious foci later than those of the parent virus Oshima 5-10 (Fig. 3) . We therefore (Fig. 1) . The viruses were compared in focus assays, growth curves, mouse neuroinvasiveness and neurovirulence. The results of these tests demonstrated that substitution of conserved (among all flaviviruses) hydroxylcontaining amino acids serine or threonine in position 40 of the E protein for the aromatic hydrophobic amino acid proline of the infectious clone was solely responsible for the delay of TBEV focus formation, delayed growth curve characteristics and reduced neurovirulence (Figs 3, 5 and 6) . Examination of the crystal structure of the E protein (Rey et al., 1995) shows that amino acid S 40 is buried within the central domain I, i.e. it is not exposed on the surface of the protein.
The effect of E-S 40 RP on virus reproduction might therefore be mediated by conformational changes that could affect virion adsorption, penetration or assembly. Proline is an aromatic amino acid, larger in size then threonine and serine, and it could induce important structural changes to the protein since proline residues are often located at the point of b-turns. Nevertheless one non-vectored flavivirusApoi virus -had an alanine in this position (Fig. 4) . Therefore it is possible to have a hydrophobic amino acid in this position, although it could change the properties of the protein. The E protein is the most studied protein of the flaviviruses because it is associated with the main biological characteristics of the virus, including virion adsorption, pH-dependent penetration, haemagglutination, induction of virus-neutralizing and protective antibodies, antibodydependent enhancement and virulence properties (Barrett & Gould, 1986; McMinn, 1997; Heinz, 2003) . Many mutations have been identified that attenuate virus reproduction through different functional regions of the E protein (Lee & Lobigs, 2000; Mandl et al., 2000 Mandl et al., , 2001 Hurrelbrink & McMinn, 2001; Holzmann et al., 1997; Allison et al., 2001; Monath et al., 2002; Cecilia & Gould, 1991; Gritsun et al., , 2001 Jiang et al., 1993; Rey et al., 1995) . At this stage of the investigations it is not possible to define the function of the E protein (adsorption, penetration or virion assembly) that was affected by the E-S 40 RP mutation.
Two nucleotide substitutions were mapped in the 39UTR. The mutation at position 10473 (position 97 after the stop codon in Oshima 5-10 virus sequence; Table 1 ) mapped in the hypervariable region of the flaviviruses (Gritsun et al., 1997; Wallner et al., 1995) that was shown not to influence flavivirus infectivity (Mandl et al., 1998 Similarly with the Siberian TBEV virus, Vs, mutations other than those in the E protein of the infectious clone O-IC, appeared to be responsible for the reduction of neurovirulence in mice, although they did not result in any biological consequences for plaque assays or growth cycle characteristics (Gritsun et al., 2001) . Two viruses, O-IC-pt and S 40 A 378 K 674 T 794 were genetically different by two amino acids within the NS5 protein (in positions 378 and 674, Fig. 2 and Table 1 ) that affected only neurovirulence and neuroinvasive properties of the virus (Fig. 6 and Table 2 ) with no effect on virus growth characteristics in BHK cell culture (Fig. 5 ). These two substitutions within the NS5 protein were of a conserved nature (V 378 RA, R 674 RK), but both were located in functionally important domains of NS5 protein, one V 378 RA in the nuclear localization sequence (Forwood et al., 1999) and the other R 674 RK in close proximity to the highly conserved GDD sequence (663-665), which is an RNA-dependent RNA polymerase motif (Rice et al., 1985; Khromykh et al., 1998) . Therefore the reduction of neurovirulence due to these two substitutions could be explained by the limitations imposed on protein tertiary structure in highly conserved domains of the NS5 protein. A similar observation for mutations within the NS5 protein and the 39UTR was previously reported for the infectious clone of the Siberian TBEV Vs virus (Gritsun et al., 2001) .
Comparative analyses of three viruses in neurovirulence tests (Fig. 6) (Gritsun et al., 2001) .
Neuroinvasiveness was also compared by subcutaneous inoculation of mice (Table 2 ). All mice inoculated with parent Oshima 5-10 virus died within 8-12 days postinoculation. Although mice inoculated with O-IC-pt virus survived until 28 days post-inoculation, some showed clinical signs such as paralysis or loss of body weight (Table 2) . Growth curve experiments also demonstrated smaller virus titres at 12 h post-infection for O-IC-pt virus in comparison with parent Oshima 5-10 virus (Fig. 5) . In view of these unexpected results, we sequenced the virus recovered from sick mice and confirmed that this O-IC-pt virus had the identical sequence to parent Oshima 5-10 virus. One possible explanation for this result may be that the parent Oshima 5-10 virus consists of a population of quasi-species. Since the parent Oshima 5-10 virus sequence had been determined by direct-sequencing from RT-PCR products (Hayasaka et al., 1999; Goto et al., 2002) , the sequence would be a consensus. We therefore cloned parent Oshima 5-10 virus by plaque assay and noticed several different sizes of plaque (data not shown). We picked a large and a small plaque variant and determined the sequence of the E protein of each. A single but different amino acid substitution was detected in the E protein of each plaque variant. Both viruses showed less neuroinvasiveness than the parent virus (Goto et al., 2003) . Whilst we did not identify a plaque variant with the high neuroinvasiveness of the parent virus, these results combined with the concept that quasi-species may show a range of virulence characteristics, provide a rational explanation for the difference in neuroinvasiveness of parent Oshima 5-10 and O-IC-pt virus for mice. It is unlikely that other phenomena such as interferon or defective interfering particles can account for this difference in virulence because both virus stocks were prepared in the same way, that is in BHK cells. Moreover, the infectious clone was passaged only once in BHK cells which would be unlikely to generate a significant level of defective particles.
In summary, we have constructed an infectious clone based on the Far-Eastern subtype of TBEV. The original infectious clone contained four amino acid substitutions that were back-mutated to produce the infectious clone genetically identical to the parent virus. Site-directed mutagenesis on the infectious clone revealed that one amino acid, P 40 , in the E protein and two amino acids, A 378 and K 674 , in the NS5 protein were responsible for the virus attenuation. We also demonstrated the cumulative effect of point mutations on attenuated characteristics of TBEV.
